Literature DB >> 25308733

Metastasis of human gastric adenocarcinoma partly depends on phosphoinositide-specific phospholipase γ1 expression.

Luhua Zhuang, Bingchang Zhang, Guoqing Zeng, Lianzhi Dai, Hongliu Qian, Tianhui Hu, Gang Song, Bing Zhang, Chun Xia1.   

Abstract

It is known that phosphoinositide-specific phospholipases γ1(PLCγ1) can trigger several signalling pathways to regulate cell proliferation, differentiation, and metastasis. However, whether this kinase is highly expressive and active in human gastric adenocarcinomas, and whether it can play an important role in the development of the cancer, have not yet been investigated. The aim of the study was to investigate the expression of PLCγ1 in human gastric adenocarcinoma, while the question of whether PLCγ1 can be activated through protein kinase B (Akt) signalling pathways to regulate cell migration was further explored using human gastric adenocarcinoma BGC-823 cell line. The expression of PLCγ1 in human adenocarcinoma was detected using immunohistochemical staining. The BGC-823 cells were cultured and treated with inhibitors or transfected with plasmid construction. The cell migration of BGC-823 cells was measured with wound healing assay, cell migration assay, and the ruffling assay. The expression levels of PLCγ1 and its related signal molecules in BGC-823 cells were assessed using Western blot analysis or gelatine zymography assay. PLCγ1 was highly expressed in humangastric adenocarcinomas, especially in the region with lymph node metastasis. It was shown that migration of BGC-823 cells in vitro depends on PLCγ1 activation. This activation is mediated through Akt, an upstream of PLCγ1 that triggers the PLCγ1/extracellular signal-regulated kinase (ERK)/matrix metalloproteinase (MMP) pathway in BGC-823 cells. PLCγ1 activities play an important role in the metastasis of gastric adenocarcinoma, and may serve as a potential therapeutic target in this type of cancer.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25308733     DOI: 10.5603/FHC.2014.0021

Source DB:  PubMed          Journal:  Folia Histochem Cytobiol        ISSN: 0239-8508            Impact factor:   1.698


  6 in total

1.  The inhibition of PLCγ1 protects chondrocytes against osteoarthritis, implicating its binding to Akt.

Authors:  Heguo Cai; Ning Qu; Xiaolei Chen; Yang Zhou; Xinpeng Zheng; Bing Zhang; Chun Xia
Journal:  Oncotarget       Date:  2017-12-15

2.  Reticulocalbin 1 is required for proliferation and migration of non-small cell lung cancer cells regulated by osteoblast-conditioned medium.

Authors:  Haijing Fu; Rui Chen; Yue Wang; Yang Xu; Chun Xia; Bing Zhang
Journal:  J Cell Mol Med       Date:  2021-11-07       Impact factor: 5.310

3.  Lentivirus-mediated PLCγ1 gene short-hairpin RNA suppresses tumor growth and metastasis of human gastric adenocarcinoma.

Authors:  Bingchang Zhang; Fen Wang; Lianzhi Dai; Heguo Cai; Yanyan Zhan; Song Gang; Tianhui Hu; Chun Xia; Bing Zhang
Journal:  Oncotarget       Date:  2016-02-16

4.  DAG/PKCδ and IP3/Ca²⁺/CaMK IIβ Operate in Parallel to Each Other in PLCγ1-Driven Cell Proliferation and Migration of Human Gastric Adenocarcinoma Cells, through Akt/mTOR/S6 Pathway.

Authors:  Lianzhi Dai; Luhua Zhuang; Bingchang Zhang; Fen Wang; Xiaolei Chen; Chun Xia; Bing Zhang
Journal:  Int J Mol Sci       Date:  2015-12-01       Impact factor: 5.923

5.  Phosphoinositide-specific phospholipase Cγ1 inhibition induces autophagy in human colon cancer and hepatocellular carcinoma cells.

Authors:  Lianzhi Dai; Xiaolei Chen; Xiaohong Lu; Fen Wang; Yanyan Zhan; Gang Song; Tianhui Hu; Chun Xia; Bing Zhang
Journal:  Sci Rep       Date:  2017-10-24       Impact factor: 4.379

6.  Phosphoinositide specific phospholipase Cγ1 inhibition-driven autophagy caused cell death in human lung adenocarcinoma A549 cells in vivo and in vitro.

Authors:  Xiaohong Lu; Haijing Fu; Rui Chen; Yue Wang; Yanyan Zhan; Gang Song; Tianhui Hu; Chun Xia; Xuemei Tian; Bing Zhang
Journal:  Int J Biol Sci       Date:  2020-02-21       Impact factor: 6.580

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.